tradingkey.logo
tradingkey.logo
Search

Tango Therapeutics Inc

TNGX
Add to Watchlist
27.180USD
-0.390-1.41%
Close 07-31 16:00ETQuotes delayed by 15 min
3.69BMarket Cap
LossP/E TTM

TNGX Financials

See Tango Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Tango Therapeutics Inc Earnings Date

Latest Release
May 13, 2026
EPS / Forecast
-0.32/-0.31
Revenue / Forecast
0.00/0.00
Period
FY2025 Earnings
Revenue(YoY)
62.38M
48.29%
EPS(YoY)
-0.87
26.69%
Analyst Rating
BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
12.31%-0.32
14.57%-0.29
153.25%0.14
-49.00%-0.35
-3.14%-0.36
-16.38%-0.34
-17.15%-0.27
-0.64%-0.24
-10.37%-0.35
11.17%-0.29
---0.23
---0.23
---0.32
---0.33
---0.90
----
----
----
----
----
Revenue
-100.00%0.00
-100.00%0.00
363.61%53.81M
-83.99%3.18M
-16.67%5.39M
-24.19%4.12M
8.15%11.61M
36.15%19.88M
12.23%6.47M
-15.29%5.43M
55.09%10.73M
152.95%14.60M
0.14%5.77M
12.16%6.41M
1.96%6.92M
--5.77M
--5.76M
--5.72M
--6.79M
----
Net Profit
-14.14%-45.51M
-2.86%-38.75M
154.46%15.88M
-52.06%-38.85M
-5.17%-39.88M
-22.45%-37.67M
-31.01%-29.17M
-23.38%-25.55M
-35.37%-37.91M
-5.86%-30.76M
23.36%-22.26M
16.69%-20.71M
-11.11%-28.01M
-31.82%-29.06M
-48.29%-29.05M
-3151.11%-24.86M
-10414.11%-25.21M
-31311.72%-22.05M
-37292.63%-19.59M
---764.60K
Net Margin
----
----
111.75%29.52%
-850.08%-1221.41%
-26.22%-739.54%
-61.53%-914.99%
-21.13%-251.29%
9.38%-128.56%
-20.62%-585.91%
-24.96%-566.43%
---207.45%
---141.87%
---485.74%
---453.28%
---428.84%
----
----
----
----
----
Gross Margin
----
----
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
Revenue
-100.00%0.00
-100.00%0.00
363.61%53.81M
-83.99%3.18M
-16.67%5.39M
-24.19%4.12M
8.15%11.61M
36.15%19.88M
12.23%6.47M
-15.29%5.43M
55.09%10.73M
152.95%14.60M
0.14%5.77M
12.16%6.41M
1.96%6.92M
--5.77M
--5.76M
--5.72M
--6.79M
----
Operating profit
-14.67%-48.77M
-2.33%-41.86M
142.80%14.07M
-38.63%-40.97M
-0.65%-42.53M
-16.84%-40.91M
-28.30%-32.88M
-27.12%-29.55M
-39.52%-42.26M
-14.55%-35.01M
14.36%-25.63M
7.76%-23.25M
-19.33%-30.29M
-39.04%-30.57M
-52.91%-29.92M
-3171.99%-25.20M
-9444.75%-25.38M
-18737.08%-21.98M
-30357.59%-19.57M
---770.24K
Net Profit
-14.14%-45.51M
-2.86%-38.75M
154.46%15.88M
-52.06%-38.85M
-5.17%-39.88M
-22.45%-37.67M
-31.01%-29.17M
-23.38%-25.55M
-35.37%-37.91M
-5.86%-30.76M
23.36%-22.26M
16.69%-20.71M
-11.11%-28.01M
-31.82%-29.06M
-48.29%-29.05M
-3151.11%-24.86M
-10414.11%-25.21M
-31311.72%-22.05M
-37292.63%-19.59M
---764.60K
Current assets
74.42%392.33M
32.82%353.76M
-45.55%163.78M
-42.12%190.10M
-36.11%224.93M
-23.14%266.34M
-18.89%300.81M
2.45%328.41M
2.63%352.04M
-7.66%346.54M
-7.66%370.89M
-26.50%320.54M
-25.54%343.00M
-23.78%375.27M
-22.21%401.67M
59288.42%436.08M
31641.13%460.65M
32775.55%492.34M
31736.50%516.34M
2837.99%734.29K
Total current liabilities
-60.10%14.33M
-43.20%21.68M
-50.92%18.44M
-8.76%40.02M
-16.06%35.92M
-16.91%38.17M
-13.44%37.58M
-18.21%43.87M
-20.28%42.79M
-17.30%45.94M
-15.40%43.42M
20.03%53.63M
36.88%53.67M
36.51%55.55M
22.24%51.32M
12479.67%44.68M
12885.32%39.21M
35482.49%40.69M
36393.70%41.99M
811.61%355.21K
Total assets
58.87%435.79M
25.97%398.69M
-40.37%210.14M
-37.64%237.89M
-32.47%274.31M
-21.38%316.49M
-17.70%352.42M
0.56%381.45M
0.61%406.22M
-7.77%402.57M
-7.75%428.19M
-15.40%379.33M
-14.37%403.77M
-12.73%436.47M
-12.45%464.16M
167.62%448.40M
180.23%471.52M
197.16%500.15M
214.84%530.14M
263786.28%167.55M
Total liabilities
-58.82%44.29M
-55.11%52.51M
-59.35%50.10M
-23.06%102.94M
-24.14%107.55M
-21.73%116.97M
-18.70%123.25M
-19.60%133.78M
-19.68%141.77M
-20.07%149.46M
-20.67%151.59M
11.15%166.38M
16.76%176.51M
20.32%186.99M
16.00%191.08M
2317.77%149.69M
2362.75%151.17M
2511.63%155.41M
2667.87%164.72M
15789.79%6.19M
Total equity
134.78%391.51M
73.51%346.18M
-30.17%160.03M
-45.51%134.95M
-36.94%166.76M
-21.17%199.52M
-17.15%229.17M
16.31%247.67M
16.36%264.45M
1.46%253.11M
1.29%276.60M
-28.71%212.94M
-29.06%227.26M
-27.64%249.48M
-25.27%273.07M
85.12%298.70M
97.60%320.36M
112.33%344.75M
124.96%365.41M
657751.67%161.36M
Net operating income
-6.39%-44.36M
18.91%-29.72M
7.30%-30.95M
-54.70%-36.52M
-10.14%-41.70M
-33.42%-36.65M
-7.24%-33.39M
3.54%-23.61M
-8.45%-37.86M
2.83%-27.47M
-58.76%-31.14M
22.40%-24.47M
-17.67%-34.91M
-67.23%-28.27M
53.15%-19.61M
-4354.32%-31.54M
-53226.50%-29.66M
-6997.45%-16.90M
-46803.99%-41.86M
---708.03K
Net investment
-68.51%9.63M
-360.69%-135.72M
45.77%47.48M
32.12%16.78M
373.11%30.60M
53.79%52.06M
157.48%32.57M
-61.15%12.70M
-135.51%-11.20M
368.56%33.85M
-472.10%-56.66M
-7.91%32.69M
369.28%31.55M
72.12%-12.61M
111.01%15.23M
109065.56%35.49M
---11.72M
---45.21M
17.09%-138.26M
--32.51K
Net financing
3992200.00%79.85M
22539.42%219.38M
5.79%2.54M
-55.68%581.00K
-100.00%2.00K
-33.95%969.00K
-97.01%2.40M
123.72%1.31M
58779.45%42.98M
178.37%1.47M
70944.25%80.28M
-18.38%586.00K
-71.60%73.00K
539.17%527.00K
-99.97%113.00K
--718.00K
--257.00K
---120.00K
112.30%357.44M
----

FAQs

What is the total revenue of Tango Therapeutics Inc?

According to Tango Therapeutics Inc's FY2025 earnings report, its total revenue reached 62.38M, with a year-on-year change of 42.07M.

What are the current assets of Tango Therapeutics Inc?

According to Tango Therapeutics Inc's FY2025 earnings report, its current assets were 353.76M, with a year-on-year change of 32.82.

What are the total assets of Tango Therapeutics Inc?

According to Tango Therapeutics Inc's FY2025 earnings report, its total assets of Tango Therapeutics Inc were 398.69M, with a year-on-year change of 25.97.

What are the total liabilities of Tango Therapeutics Inc?

According to Tango Therapeutics Inc's FY2025 earnings report, its total liabilities of Tango Therapeutics Inc were 52.51M, with a year-on-year change of -55.11.

What is the total equity of Tango Therapeutics Inc?

According to Tango Therapeutics Inc's FY2025 earnings report, its total equity of Tango Therapeutics Inc was 346.18M, with a year-on-year change of 73.51.

What is the net operating income of Tango Therapeutics Inc?

According to Tango Therapeutics Inc's FY2025 earnings report, its net operating income of Tango Therapeutics Inc was -111.29M, with a year-on-year change of 23.56.

What is the net investment of Tango Therapeutics Inc?

According to Tango Therapeutics Inc's FY2025 earnings report, its net investment of Tango Therapeutics Inc was -40.87M, with a year-on-year change of -147.45.

What is the net financing of Tango Therapeutics Inc?

According to Tango Therapeutics Inc's FY2025 earnings report, its net financing of Tango Therapeutics Inc was 222.50M, with a year-on-year change of 366.81.

What is the Earnings Per Share (EPS) of Tango Therapeutics Inc?

According to Tango Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.87, with a year-on-year change of 26.69.

What is the net income of Tango Therapeutics Inc?

According to Tango Therapeutics Inc's FY2025 earnings report, its net income was -101.59M, with a year-on-year change of 22.03.

What is the net margin of Tango Therapeutics Inc?

According to Tango Therapeutics Inc's FY2025 earnings report, its net profit margin was -162.85, with a year-on-year change of 47.42.

What is the Return on Equity (ROE) of Tango Therapeutics Inc?

According to Tango Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -37.23, with a year-on-year change of 35.33.

What is the Return on Assets (ROA) of Tango Therapeutics Inc?

According to Tango Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -28.41, with a year-on-year change of 21.61.

What is the operating profit of Tango Therapeutics Inc?

According to Tango Therapeutics Inc's FY2025 earnings report, its operating profit was -111.29M, with a year-on-year change of 23.56.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.